Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus Christopher.Koski@bruker.com Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus Read More »
A Multi-Clone Kinetic Model for Characterising CHO Cell Line Variability Christopher.Koski@bruker.com A Multi-Clone Kinetic Model for Characterising CHO Cell Line Variability Read More »
Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates Christopher.Koski@bruker.com Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates Read More »
Human endogenous retrovirus K (HERV-K) envelope structures in pre- and postfusion by cryo-EM Christopher.Koski@bruker.com Human endogenous retrovirus K (HERV-K) envelope structures in pre- and postfusion by cryo-EM Read More »
High-throughput single-cell analysis reveals fully human Omp38-specific monoclonal antibodies against Acinetobacter baumannii Christopher.Koski@bruker.com High-throughput single-cell analysis reveals fully human Omp38-specific monoclonal antibodies against Acinetobacter baumannii Read More »
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation Christopher.Koski@bruker.com Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation Read More »
Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment Christopher.Koski@bruker.com Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment Read More »
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors Christopher.Koski@bruker.com CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors Read More »
Cross-reactive sarbecovirus antibodies induced by mosaic RBD-nanoparticles simplomarketing Cross-reactive sarbecovirus antibodies induced by mosaic RBD-nanoparticles Read More »
A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs Christopher.Koski@bruker.com A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs Read More »
